These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38923428)
1. Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Kato Y; Matsumoto M; Takano N; Hirao M; Matsuda K; Tozuka T; Onda N; Nakamichi S; Takeuchi S; Miyanaga A; Noro R; Gemma A; Seike M Cancer Med; 2024 Jun; 13(12):e7393. PubMed ID: 38923428 [TBL] [Abstract][Full Text] [Related]
2. Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial. Yılmaz F; Yaşar S; Mandel NM; Kaçan T; Özdemir M; Doğu GG; Şengül N; Meydan N; Başal FB; Tolunay PK; Hamamcı MB; Dinçer OS; Bahçeci A; Özer L; Ajredini M; Kırca Ö; Yersal Ö; Can O; Günaldı M; Demir G; Yalçın Ş Target Oncol; 2024 Nov; 19(6):957-964. PubMed ID: 39317891 [TBL] [Abstract][Full Text] [Related]
3. Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas. Kummar S; Shen L; Hong DS; McDermott R; Keedy VL; Casanova M; Demetri GD; Dowlati A; Melcón SG; Lassen UN; Leyvraz S; Liu T; Moreno V; Patel J; Patil T; Mallick AB; Sousa N; Tahara M; Ziegler DS; Norenberg R; Arvis P; Brega N; Drilon A; Tan DSW Cancer; 2023 Dec; 129(23):3772-3782. PubMed ID: 37769113 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
5. Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer. Smith MR; Dixon CB; Wang Y; Liu Y; D'Agostino R; Ruiz J; Oliver G; Miller LD; Topaloglu U; Chan MD; Farris M; Su J; Mileham KF; Zhao D; Li W; Sexton T; Lycan T; Haas KM; Grayson JM; Xing F Cancer Res; 2024 Dec; 84(23):4002-4016. PubMed ID: 39250241 [TBL] [Abstract][Full Text] [Related]
6. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
8. STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma. Lu D; Li Y; Niu X; Sun J; Zhan W; Shi Y; Yu K; Huang S; Liu X; Xie L; Ma X; Liu B Research (Wash D C); 2024; 7():0539. PubMed ID: 39600540 [No Abstract] [Full Text] [Related]
9. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
10. A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma. Li H; Liu H; Xiao L; Gao H; Wei H; Han A; Lin G Curr Oncol; 2024 Oct; 31(11):6621-6631. PubMed ID: 39590120 [TBL] [Abstract][Full Text] [Related]
14. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
15. Strategies to improve smoking cessation rates in primary care. Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994 [TBL] [Abstract][Full Text] [Related]
16. Behavioural interventions to treat anxiety in adults with autism and moderate to severe intellectual disabilities: the BEAMS-ID feasibility study. Langdon PE; Apanasionok MM; Scripps E; Bunning K; Filipczuk M; Gillespie D; Hastings RP; Jahoda A; McNamara R; Rai D; Gray KM Health Technol Assess; 2024 Oct; 28(72):1-147. PubMed ID: 39487624 [TBL] [Abstract][Full Text] [Related]
17. A Blog-Based Study of Autistic Adults' Experiences of Aloneness and Connection and the Interplay with Well-Being: Corpus-Based and Thematic Analyses. Petty S; Allen S; Pickup H; Woodier B Autism Adulthood; 2023 Dec; 5(4):437-449. PubMed ID: 38116056 [TBL] [Abstract][Full Text] [Related]
19. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1. Sun T; Lin B; Sun Q; Zhang X; Wang T; Yang J; Liu X; Lu H; Lu N; Zhao K Phytomedicine; 2024 Dec; 135():156070. PubMed ID: 39326139 [TBL] [Abstract][Full Text] [Related]